Northwest Biotherapeutics, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Northwest Biotherapeutics, Inc. (NWBO) is 345.80M

According to Northwest Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 345.80M. This represents a change of -12.24% compared to the average of 394.05M of the last 4 quarters.

Northwest Biotherapeutics, Inc. (NWBO) Historical Enterprise Value (quarterly & annually)

How has NWBO Enterprise Value performed in the past?

The mean historical Enterprise Value of Northwest Biotherapeutics, Inc. over the last ten years is 457.43M. The current 345.80M Enterprise Value has changed -24.40% with respect to the historical average. Over the past ten years (40 quarters), NWBO's Enterprise Value was at its highest in in the December 2020 quarter at 1.28B. The Enterprise Value was at its lowest in in the June 2017 quarter at 65.36M.

Northwest Biotherapeutics, Inc. (NWBO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Northwest Biotherapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Northwest Biotherapeutics, Inc. (NWBO) Average Enterprise Value

How has NWBO Enterprise Value performed in the past?

The current Enterprise Value of Northwest Biotherapeutics, Inc. (NWBO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Northwest Biotherapeutics, Inc. (NWBO) Enterprise Value vs. Peers

How is NWBO’s Enterprise Value compared to its peers?

Northwest Biotherapeutics, Inc.’s Enterprise Value is less than ImmunityBio, Inc. (10.20B), greater than CEL-SCI Corporation (25.64M), greater than Coherus Oncology, Inc. (86.14M), greater than NovaBridge Biosciences (-69760286.00), greater than ALX Oncology Holdings Inc. (175.07M), less than Celldex Therapeutics, Inc. (2.31B), greater than MacroGenics, Inc. (68.33M), greater than Atara Biotherapeutics, Inc. (90.67M), greater than Century Therapeutics, Inc. (287.38M), greater than Crescent Biopharma, Inc. (343.17M),

Build a custom stock screener for Northwest Biotherapeutics, Inc. (NWBO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Northwest Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Northwest Biotherapeutics, Inc. (NWBO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Northwest Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.